Crdf stocktwits.

A high-level overview of Cardiff Oncology, Inc. (CRDF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Cardiff Oncology is a clinical-stage oncology company, developing new precision medicine treatment options for cancer patients in indications with the greatest unmet medical need including KRAS-mutated colorectal cancer, pancreatic cancer, and castrate-resistant prostate cancer. "There is currently only a 5-13% response rate to second-line ...As of June 30, 2023, Cardiff Oncology had approximately $89.4 million in cash, cash equivalents, and short-term investments. Net cash used in operating activities for the second quarter of 2023 ...Track Cardiff Oncology Inc (CRDF) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors.

The Cardiff Oncology Inc. stock price gained 2.01% on the last trading day (Friday, 26th Apr 2024), rising from $3.99 to $4.07. During the last trading day the stock fluctuated 3.74% from a day low at $3.98 to a day high of $4.13. The price has fallen in 7 of the last 10 days and is down by -27.45% for this period.Aug 22, 2022 · Cardiff Oncology is a small oncology firm based in San Diego. The one key asset in this company's pipeline is a drug candidate called Onvansertib. This compound is an oral and highly selective ... Track Inmode Ltd (INMD) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

Real-Time Quotes After-Market Quotes. Get the latest updates on Cardiff Oncology, Inc. Common Stock (CRDF) pre market trades, share volumes, and more. Make informed investments with Nasdaq.

CRDF Stock 12 Month Forecast. $10.50. (140.27% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Cardiff Oncology in the last 3 months. The average price target is $10.50 with a high forecast of $14.00 and a low forecast of $7.00. The average price target represents a 140.27% change from the last price of $4.37.Track Crowdstrike Holdings Inc (CRWD) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Ardelyx Inc (ARDX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsView the latest Cardiff Oncology Inc. (CRDF) stock price, news, historical charts, analyst ratings and financial information from WSJ.

CRDF | January 17, 2024. - Findings from the Phase 1b portion of company's Phase 1b/2 study in second-line KRAS-mutated mCRC highlight the safety and promising efficacy of onvansertib in combination with standard-of-care -. - These peer-reviewed published data are part of the Phase 1b/2 data Cardiff Oncology announced in August 2023 and ...

Find the latest Insider Activity data for Cardiff Oncology, Inc. Common Stock (CRDF) at Nasdaq.com.

SA Transcripts. 146.31K Follower s. Play Earnings Call. Cardiff Oncology, Inc. ( NASDAQ: CRDF) Q1 2024 Results Earnings Conference Call May 2, 2024 4:30 PM ET. Company …Cardiff Oncology, Inc. Trovagene, Inc. is a clinical-stage, precision cancer medicine oncology therapeutics company, which engages in the development of drugs that target cell division (mitosis), for the treatment of various cancers … Featured Post From StockTwits About CRDF This is just my opinion, and it's only slightly rooted in what I believe to be factual. So take my speculation for what it might be worth. Mar 1, 2024 · Play Earnings Call. Cardiff Oncology, Inc. ( NASDAQ: CRDF) Q4 2023 Earnings Conference Call February 29, 2024 4:30 PM ET. Company Participants. Laurence Watts - Investor Relations, Gilmartin Group ... Cardiff Oncology, Inc. Trovagene, Inc. is a clinical-stage, precision cancer medicine oncology therapeutics company, which engages in the development of drugs that target cell division (mitosis), for the treatment of various cancers including leukemia, lymphomas, and solid tumors.

Analyze Stocktwits Mentions for Cardiff Oncology and gain a competitive edge with unique and comprehensive information. Datasets; Top Stocks. Stock Screener . ... Cardiff Oncology (CRDF) - Stocktwits Mentions. Sign up to add (CRDF) to your portfolio and access more historical data. 13 85.7% 1W 87.5% 1M 56.7%According to the issued ratings of 2 analysts in the last year, the consensus rating for Cardiff Oncology stock is Buy based on the current 2 buy ratings for CRDF. The average twelve-month price prediction for Cardiff Oncology is $10.50 with a high price target of $14.00 and a low price target of $7.00. Learn more on CRDF's analyst rating …Find the latest Cardiff Oncology, Inc. (CRDF) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest CytoDyn Inc. (CYDY) stock quote, history, news and other vital information to help you with your stock trading and investing.Track Cardiol Therapeutics Inc - Ordinary Shares - Class A (CRDL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsStock Price Forecast. The 2 analysts with 12-month price forecasts for Cardiff Oncology stock have an average target of 10.5, with a low estimate of 7.00 and a high estimate of 14. The average target predicts an increase …

SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of ...

CRDF. Edit my quotes. 0. Add to Watchlist. Add to Portfolio. CRDF CRDF REAL TIME. CRDF Real-Time Quotes. 1D. 5D 1M 6M YTD 1Y 5Y MAX. Last Five Real-Time Trades. …Cardiff Oncology, Inc. Common Stock (CRDF) 0. Add to Watchlist. Add to Portfolio. Summary. Real-Time. After-Hours. Pre-Market. Charts. PreviousClose. Key Data. Label. … Find the latest Cardiff Oncology, Inc. (CRDF) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. A high-level overview of Cellectis S.A. (CLLS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.54K subscribers in the antivirus community. For all of your Antivirus NeedsFind the latest Cardiff Oncology, Inc. (CRDF) stock quote, history, news and other vital information to help you with your stock trading and investing.

Track Cardiol Therapeutics Inc - Ordinary Shares - Class A (CRDL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

SAN DIEGO, Feb. 29, 2024 (GLOBE NEWSWIRE) — Cardiff Oncology, Inc. CRDF, a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced financial results for the fourth quarter and full year ended December 31, 2023, and provided a business update.

According to the issued ratings of 2 analysts in the last year, the consensus rating for Cardiff Oncology stock is Buy based on the current 2 buy ratings for CRDF. The average twelve-month price prediction for Cardiff Oncology is $10.50 with a high price target of $14.00 and a low price target of $7.00. Learn more on CRDF's analyst rating …Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. It is focused on developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted ...Cardiff Oncology is a small oncology firm based in San Diego. The one key asset in this company's pipeline is a drug candidate called Onvansertib. This compound is an oral and highly selective ... At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. A high-level overview of Cardiff Oncology, Inc. (CRDF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Cardiff Oncology Inc. $4.07. After Hours: $4.17. (2.46%) +0.100. Closed: Apr 26, 5:20:00 PM GMT-4 · USD · NASDAQ · Disclaimer. 1D. 5D. 1M. 6M. YTD. 1Y. 5Y. MAX. search …Track Cornerstone Total Return Fund Inc. (CRF) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsCardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that it plans to ...

4. ($1.17) ($1.17) ($1.17) CRDF Earnings Date and Information. Cardiff Oncology last posted its earnings results on February 29th, 2024. The reported ($0.21) earnings per share for the quarter, beating analysts' consensus estimates of ($0.26) by $0.05. The business earned $0.16 million during the quarter, compared to analysts' …Track Cardio Diagnostics Holdings Inc (CDIO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Bitcoin(BTC) Price, real-time chart movements, latest community messages, chart, news and related information. Share your ideas and get valuable insights from the community of like minded traders and investorsCRDF Stock 12 Month Forecast. $10.50. (140.27% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Cardiff Oncology in the last 3 months. The average price target is $10.50 with a high forecast of $14.00 and a low forecast of $7.00. The average price target represents a 140.27% change from the last price of $4.37.Instagram:https://instagram. o'reilly wrens gathree line poem crossword clueis doug bishop still with adventures with purpose 2023amsco chapter 19 Cardiff Oncology EPS misses by $0.27. A high-level overview of Cardiff Oncology, Inc. (CRDF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and ... newport arkansas shootingturn style chandler Track Credo Technology Group Holding Ltd (CRDO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsClinical-stage biotech Cardiff Oncology (CRDF) added ~14% in the pre-market trading Monday after the company announced Phase 1b/2 data for its lead asset Onvansertib in patients... ihop mission grove Cardiff Oncology is a small oncology firm based in San Diego. The one key asset in this company's pipeline is a drug candidate called Onvansertib. This compound is an oral and highly selective ...Track Acreage Holdings Floating Subordinate Voting Class D Ord Shs (ACRDF) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the … The latest messages and market ideas from Crdf (@Crdf) on Stocktwits. The largest community for investors and traders